[HTML][HTML] Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic …
M Casile, G Albrand, B Lebecque, J Besombes… - BMC cancer, 2024 - Springer
Background In the era of targeted therapies, the influence of aging on cancer management
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid …
M Casile, G Albrand, B Lebecque… - BMC …, 2024 - pubmed.ncbi.nlm.nih.gov
Background In the era of targeted therapies, the influence of aging on cancer management
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
[HTML][HTML] Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic …
M Casile, G Albrand, B Lebecque, J Besombes… - BMC Cancer, 2024 - ncbi.nlm.nih.gov
Background In the era of targeted therapies, the influence of aging on cancer management
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
[HTML][HTML] Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic …
M Casile, G Albrand, B Lebecque… - BMC …, 2024 - bmccancer.biomedcentral.com
In the era of targeted therapies, the influence of aging on cancer management varies from
one patient to another. Assessing individual frailty using geriatric tools has its limitations …
one patient to another. Assessing individual frailty using geriatric tools has its limitations …
Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid …
M Casile, G Albrand, B Lebecque, J Besombes… - BMC Cancer, 2024 - europepmc.org
Background In the era of targeted therapies, the influence of aging on cancer management
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
[PDF][PDF] Mélanie Casile1, 3, Gilles Albrand2, Benjamin Lebecque1, 3, Joévin Besombes1, 3, Céline Bourgne1, 3, Bruno Pereira4
S Saugues, C Jamot, E Hermet, MG Berger - 2024 - bmccancer.biomedcentral.com
Background In the era of targeted therapies, the influence of aging on cancer management
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
varies from one patient to another. Assessing individual frailty using geriatric tools has its …